ArticleProceedings of the National Academy of Sciences of the United States of America2013

Histone deacetylase inhibitors increase glucocerebrosidase activity in Gaucher disease by modulation of molecular chaperones.

Chunzhang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.